# A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors

> **NCT06752447** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shandong New Time Pharmaceutical Co., LTD** · enrollment: 94 (estimated)

## Conditions studied

- Advanced Solid Tumors (Phase 1)

## Interventions

- **DRUG:** LNF2007

## Key facts

- **NCT ID:** NCT06752447
- **Lead sponsor:** Shandong New Time Pharmaceutical Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752447, "A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06752447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*